MedTrace Logo

Nobori And Uncoated Stent In Coronary Attack

NCT01401036 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1537

Last updated 2018-08-27

No results posted yet for this study

Summary

Drug-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of Nobori (Biolimus A9 Eluting Stent) in primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Accordingly, the investigators will compare the outcomes of primary PCI for AMI between patients receiving Nobori versus uncoated stents.

Conditions

  • Acute Myocardial Infarction

Interventions

DEVICE

Biolimus A9 eluting stents

implantation of Biolimus A9 eluting stents

PROCEDURE

uncoated stent

implantation of any uncoated bare metal stents currently available in Japan

Sponsors & Collaborators

  • NPO International TRI Network

    collaborator NETWORK

  • Shigeru Saito

    lead NETWORK

Principal Investigators

  • Shigeru Saito, MD · NPO International TRI Network

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-08-05
Completion
2017-12-07

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401036 on ClinicalTrials.gov